GLP-1 Side Effects Timeline: The Quick Answer Week 1 may bring nausea, reduced appetite, fullness, bloating, diarrhea, or constipation, although some people notice few symptoms
Your weekly Retatrutide injection follows the exact same principles refined through decades of medical practice
Our cagrilintide with retatrutide dosing guide covers the theoretical framework for researchers considering this approach
For current pricing on compounded retatrutide, see our [cost guide](/guides/retatrutide-cost-price-guide-2026)
FDA Guidelines on Long-Term Tirzepatide Use The FDA examines clinical trial data to prove that tirzepatide is safe to use beyond the initial stages
Triple-Hormone-Receptor Agonist Retatrutide for Obesity - A Phase 2 Trial (PubMed record)